Antibiotic prescribing in two private sector hospitals; one teaching and one non-teaching: A cross-sectional study in Ujjain, India by Megha Sharma et al.
RESEARCH ARTICLE Open Access
Antibiotic prescribing in two private sector
hospitals; one teaching and one non-teaching: A
cross-sectional study in Ujjain, India
Megha Sharma1,2, Bo Eriksson3, Gaetano Marrone2, Suryaprakash Dhaneria1 and Cecilia Stålsby Lundborg2*
Abstract
Background: The worldwide increase in antibiotic resistant bacteria is of great concern. One of the main causes is
antibiotic use which is likely to be high but is poorly described in India. The aim was to analyze and compare
antibiotic prescribing for inpatients, in two private sector tertiary care hospitals; one Teaching and one Non-
teaching, in Ujjain, India.
Methods: A cross-sectional study with manual data collection was carried out in 2008. Antibiotic prescribing was
recorded for all inpatients throughout their hospital stay. Demographic profile of inpatients and prescribed
antibiotics were compared. WHO Anatomical Therapeutic Chemical (ATC) classifications for antibiotics was used and
Defined Daily Doses (DDD) were calculated per patient day.
Results: A total of 8385 inpatients were admitted during the study period. In the Teaching hospital (TH) 82% of
3004 and in the Non-teaching hospital (NTH) 79% of 5381 patients were prescribed antibiotics. The most
commonly prescribed antibiotic groups were; fluoroquinolones and aminoglycosides in the TH and, 3rd generation
cephalosporins and combination of antibiotics in the NTH. Of the prescriptions, 51% in the TH and 87% in the NTH
(p<0.001) were for parenteral route administration. Prescribing by trade name was higher in the NTH (96%)
compared with the TH (63%, p<0.001).
Conclusions: The results from both hospitals show extensive antibiotic prescribing. High use of combinations of
antibiotics in the NTH might indicate pressure from pharmaceutical companies. There is a need to formulate and
implement; based on local prescribing and resistance data; contextually appropriate antibiotic prescribing
guidelines and a local antibiotic stewardship program.
Background
Antibiotics are widely used medicines to treat both life
threatening and trivial infections. Their indiscriminate
use increases the risk of bacterial drug resistance [1, 2].
High incidences of infectious diseases, high usage of
antibiotics [3-5] and bacterial resistance [6] are reported
from low and middle income countries. Resistant bac-
teria spread rapidly in these countries due to setting spe-
cific factors, such as overcrowding, poor sanitation, and
a warm-humid climate. Rising rates of bacterial resist-
ance is increasingly seen as a global problem [7-10].
Although 70% of the 1028 million people living in
India live in rural areas about 80% of doctors, 75% of
dispensaries and 60% of hospitals are located in urban
areas [11, 12]. Healthcare is provided through both pub-
lic and private sector facilities. The public sector, regu-
lated by state government, provides medical care either
free or with nominal charges, and is obliged to follow
national prescribing guidelines. In the private sector,
patients generally pay for clinical and medical services.
In India, studies on the use of antibiotics have mainly
been conducted in public sector facilities, rather than
private settings [13-16] where prescribing guidelines are
often not implemented [17].
About 80% of the healthcare in India is provided by
the private sector, and 93% of hospitals are private
[12,18,19]. Hospitals are key places for antibiotic use
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and therefore settings for the selection and spread of
resistant bacteria between patients, and finally in to
the community [20-22].
This study is part of a larger project with the long
term aim to formulate context relevant guidelines for
the rational use of antibiotics in the study hospitals,
thereby minimizing the cost of therapy and the risk of
emergence of resistant organisms. The aim of this study
was to analyze and compare antibiotic prescribing pat-
terns for inpatients in two tertiary care hospitals both
from private sector (one Teaching and one Non-
teaching), in Ujjain district, India.
Methods
Setting and design
Madhya Pradesh (MP) is one of the so called BIMARU
[23, 24] states of India. BIMARU is an acronym of the
Indian states; Bihar, Madhya Pradesh, Rajasthan and
Uttar Pradesh. The term BIMARU resembles to a Hindi
word “Bimar” which means ‘sick’. These states are lag-
ging behind in economic and social development indi-
ces, as well as in healthcare performance with high
infant and maternal mortality rates as compared with
other states in India.
The study was conducted in the Ujjain district of MP.
This has a mainly agriculture-based economy, and 61%
of its 1.7 million inhabitants [11] live in rural areas. Only
23% of the villages in the district have any public med-
ical facility [25].
The two study hospitals are both from the private sec-
tor and are tertiary care hospitals with microbiological
investigational facilities. In this paper the ‘Teaching hos-
pital’ will be referred to as TH and the ‘Non-teaching
hospital’ as NTH. The TH (570 beds) was established in
a rural area in the year 2005 and had inadequate trans-
port facilities at the time of study. It is associated with a
private medical college and provides free care to all
patients. All the consultants in the TH receive fixed
monthly salary. The management at the TH controls the
purchase and supply of all medicines, which are subse-
quently dispensed free of charge to the patients. In the
TH the generic medicines are purchased from permitted
marketers.
The NTH (350 beds) was established in 1992 in the
city centre and is easily accessible. Patients pay for care
and no managerial control is present over prescribing
practices. The prescribed medicines must be purchased
by patients from pharmacies also during their hospital
stay. The consultants receive extra payment for the
numbers of patients they admit.
There were 11 departments in each hospital; of which
10 were comparable. The casualty inpatient department
was present only in the TH and the private ward (pre-
sented as a department in this paper), only in the NTH.
A local Essential Drug List was available in the TH but
was not fully implemented. Local prescribing guidelines
had not been formulated for either of these hospitals. In
both hospitals patients are admitted from nearby villages
and Ujjain city.
Hence, both the study hospitals are tertiary care hospi-
tals from the private sector of the same district but they
differ in location, type etc. The two hospitals were com-
pared as factors, like service (free or charged), policy of
payment to the prescribers, type of hospital (teaching or
non teaching), location (rural or urban) etc. varied and
might influence the antibiotic prescribing.
This was a cross-sectional study with data collection
from April to August 2008. These are the hotter months
of the year when infectious diseases such as diarrhoea
are more frequent. The study included all ‘inpatients’,
defined as patients who stayed for at least one night in
either of the hospitals. Each time a patient was admitted
to a department he/she was considered as a new patient.
In this paper an inpatient that was prescribed one or
more antibiotics at any stage during their hospital stay is
defined as an ‘antibiotic patient’. The term ‘antibiotic’ is
used for ‘anti-infectives for systemic use’ (antibacterials-
J01 and anti-mycobacterials-J04), as classified by World
Health Organization Collaborating Center for Drug Sta-
tistics Methodology [26] (WHOCC).
Data collection
The data were collected manually by the nursing staff as
there were no computerized prescribing records. The form
used for data collection was specifically developed for the
study and included patient’s name, age and sex, inpatient
department number, admission and discharge dates as
well as details of any antibiotics that had been pre-
scribed (generic or trade name, dose and frequency).
The form was prepared in English as the majority of the
nurses were from South India and well versed in Eng-
lish. The nurses were trained for data collection and
training was repeated for newly recruited staff. The
form was pink and easily visible among the white papers
of the patient file, so as to minimize the risk of missing
data. One form was attached to each patient’s file on the
day of admission and updated daily until final discharge
or death. Thus, antibiotic prescribing was recorded for
each inpatient in both hospitals during their entire
hospitalization period. Computer operators were trained
for data entry.
Prescribed antibiotics were classified by generic names
and according to the WHO Anatomical Therapeutic
Chemical Classification (ATC) [26]. Defined Daily Dose
(DDD) was used as a unit to calculate the total antibio-
tics prescribed [26]. Some of the prescribed fixed dose
combinations (FDCs) are not listed by the WHOCC,
and therefore do not have ATC codes. We coded such
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combinations following the advice of the WHOCC and
the ATC methodology up to 4th level (*J01RA).
Statistical analysis
The data was entered in Epi info (version 3.1) and Excel,
and statistical analysis was completed using Stata 10.0
software (Stata Corp. College Station, Texas, USA). Fre-
quencies and percentages were calculated for categorical
variables; sum, mean, median and range for numerical
variables. Chi square tests were used to compare the
data between the two hospitals. The study was approved
by the ethics committee of R. D. Gardi Medical College,
Ujjain (approval number 41/2007).
Results
In total, 8385 patients were admitted, 3004 in the TH
and 5381 in the NTH (Table 1). Antibiotic prescribing
during hospital stay was common in both hospitals, and
significantly higher in the TH (82%) compared with the
NTH (79%, p = 0.003). Male patients (84% and 81%)
were prescribed antibiotics more often than female
patients (77% and 79%) in the TH and the NTH respect-
ively. This difference was statistically significant in both
hospitals (TH-p <0.001; NTH-p = 0.003). A higher per-
centage of the patients in the NTH (13%) than in the
TH (6% p<0.001) were in the age group 0–4 years. The
highest percentage of patients prescribed antibiotics in
the NTH were of 0–4 years of age. Young female
patients (15–18 years) were prescribed antibiotics more
often than young males, 78% and 68% respectively, in
the TH. The opposite was observed in the NTH, 78%
and 86%. A lower percentage of females than males,
60 years and older, were prescribed antibiotics in both
hospitals.
A single antibiotic was prescribed to 44% and 66% of
antibiotic patients and two antibiotics were prescribed
to 31% and 24% antibiotic patients in the TH and the
NTH, respectively. More than five antibiotics were pre-
scribed to 3% of antibiotic patients during their hospital
stay in the TH, and 0.02% in the NTH. Antibiotics were
prescribed to be administered parenterally in 51% and
87% of prescribing occasions in the TH and the NTH,
respectively (p<0.001). Antibiotics were prescribed for
more than two weeks in 3% of antibiotic patients in the
TH and in 0.2% in the NTH. A few patients (TH n= 9
out of 3004, NTH n= 22 out of 5381) were prescribed
antibiotics at discharge, but not during their stay in
hospital.
With respect to inter-departmental differences (Table 2),
the highest percentage of patients prescribed antibiotics
in the TH were in the ophthalmology department (99%),
and in the NTH in the Neonatal Intensive Care Unit
(NICU) (91%). The highest percentage of patients pre-
scribed antibiotics after discharge was in the ophthal-
mology (83%) in the TH, and in the surgery department
(55%) in the NTH. A significantly lower percentage of
female antibiotic patients (26%) as compared with males
(32%, p<0.001), were prescribed antibiotics after dis-
charge in the NTH but there was no significant differ-
ence in the TH. The overall percentage of antibiotics
prescribed after discharge was higher in the TH (35%)
than in the NTH (29%, p<0.001). In the NICU of the
NTH, 11% of patients were prescribed antibiotics after
discharge, but none in the TH.
Both median duration of hospitalization (6 versus 3 days)
and median duration of antibiotic therapy (6 versus 4 days)
were higher in the TH than in the NTH respectively
(Table 3). DDD per antibiotic patient varied between 0.6
and 22 in the TH, and between 1 and 19 in the NTH.
DDD per day generally varied between 1 and 2 in both
hospitals, but for the NICU it was much less. DDDs were
not specified by WHOCC for antibiotics in 9% of pre-
scribing occasions in the TH and 3% in the NTH.
Trade name prescribing was more common in the
NTH (96% out of a total of 412 antibiotics prescribed)
than in the TH (63% of a total of 146). Greater adher-
ence to the National List of Essential Medicines (NEDL)
[27] and the WHO Model List of Essential Medicines
(WHO EDL) [28] was seen in the TH (NEDL-82% and
WHO EDL-72%) than in the NTH (NEDL-53%, p<0.001
and WHO EDL-35%, p<0.001). In the TH the most com-
monly prescribed antibiotics were ciprofloxacin (18%),
metronidazole (14%), doxycycline and amikacin (7% each).
In the NTH, ceftriaxone (21%), ceftriaxone with sulbac-
tam (9%), amikacin and metronidazole (8% each) and
cefoperazone with sulbactam (7%) were the most pre-
scribed antibiotics. Oral metronidazole was more fre-
quently prescribed in the TH (7%) than in the NTH
(0.3%). A combination of ampicillin with cloxacillin was
prescribed in 6% of prescribing occasions in the TH and
in 1% occasions in the NTH.
Table 1 Distribution by age and sex of inpatients with
percentages (in brackets) of patients that were
prescribed antibiotics during their stay in a Teaching and
a Non-teaching hospital in Ujjain district, India
Age Teaching hospital Non-teaching hospital
In Years Total Male Female Total Male Female
0-4 179 (61) 101 (61) 78 (60) 689 (86) 403 (86) 286 (85)
5-18 337 (72) 192 (68) 145 (78) 486 (83) 324 (86) 162 (78)
19-29 533 (87) 230 (89) 303 (85) 1106 (80) 457 (85) 649 (77)
30-49 938 (84) 483 (87) 455 (82) 1465 (80) 767 (79) 698 (81)
50-59 369 (84) 204 (89) 165 (77) 480 (74) 299 (75) 181 (73)
60 and
above
648 (84) 445 (89) 203 (73) 1155 (74) 713 (77) 442 (70)
Total 3004 (82) 1655 (84) 1349 (79) 5381 (79) 2963 (81) 2418 (77)
Age: As recorded at the time of admission.
Sharma et al. BMC Infectious Diseases 2012, 12:155 Page 3 of 9
http://www.biomedcentral.com/1471-2334/12/155
The most commonly prescribed antibiotic groups
(Table 4), in the TH were fluoroquinolones (23%), ami-
noglycosides (13%) and 3rd generation cephalosporins
(12%), accounting for 48% of the total 30311 prescribing
occasions. In the NTH the most commonly prescribed
antibiotic groups were 3rd generation cephalosporins
(31%), FDC of antibiotics (*J01RA) (25%) and fluoroqui-
nolones (12%), accounting for 68% of the total 35534
prescribing occasions. Prescribing of anti-mycobacterials
(J04) was significantly higher in the TH (8%) than in the
NTH (0.2%, p< 0.001).
Discussion
This is the first study which provides a detailed description
of the antibiotic prescribing patterns for individual inpati-
ents in two private sector hospitals in India. Previous stud-
ies have been age, department or disease specific; carried
out in public sector settings; or in outpatient departments
or commonly used comparatively less labor intensive com-
puterized or aggregated pharmacy data [13-15, 29-32]. As
the private sector is a major contributor to healthcare de-
livery in India, this study contributes substantially to an
understanding of the antibiotic prescribing patterns in the
setting. A lack of computerized data makes a detailed
study, like this, a time consuming and onerous exercise
but at the same time leads to relatively more accurate de-
scription of the prescribing patterns.
Despite the presence of a microbiology laboratory in
both hospitals, clinical samples were seldom sent for cul-
ture and sensitivity testing. Thus antibiotic prescribing
in both hospitals was mainly empirical. The presence of
controls in purchase and supply of medicines in the TH,
seem to have encouraged generic prescribing and reduced
the numbers and groups of antibiotics prescribed in the
TH. In the NTH the antibiotics were mainly prescribed by
trade names. Prescribing of generic medicines offers uni-
formity, comprehension and convenience [33, 34] whereas
prescribing by trade names supports a specific company
and is generally not as cost effective.
In both cases, both for medicines marketed under
trade names and for generic medicines, the quality of
the drug at consumption is important. There is always a
risk of fake or low-quality products available in the mar-
ket from the producer [35, 36]. This can be due to delib-
erate or unintentional factors during production or
storage. Some antibiotics can be sensitive to, for ex-
ample, hot and humid storage conditions. The presence
of fake or low-quality medicines is a serious problem
and stresses the importance of quality assurance during
production, during the procedure of market permission
and afterwards. Checking the quality of the medicines
prescribed in the two hospitals was, however, not within
the scope of this study.
A regular inflow of antibiotics with new trade names
and newer combinations was observed throughout the
study. As there is no complete list of the medicines that
are available in India, finding the name of the active sub-
stance(s) for newer non-listed trade names was time
consuming.
Pharmaceutical companies pursue prescribers via med-
ical representatives (MRs) for prescribing new FDCs of
antibiotics [37-39]. Parenteral prescribing and prescribing
of newer and broad spectrum antibiotics were higher in
the NTH than in the TH. One of the reasons might be
Table 2 Distribution of admitted patients and patients prescribed antibiotics; by department and sex in a Teaching
and a Non-teaching hospital in Ujjain district, India
Department Teaching hospital Non-teaching hospital
Total Male Female Total Male Female
Pediatric 229 (48) [5] 132 (45) [6] 97 (52) [3] 638 (83) [30] 453 (84) [29] 185 (82) [31]
NICU 16 (69) [0] 5 (60) [0] 11 (73) [0] 219 (91) [11] 91 (91) [13] 128 (91) [9]
Medicine 675 (71) [21] 289 (77) [18] 386 (67) [23] 1629 (73) [21] 831 (76) [22] 798 (69) [20]
Ob-Gy 216 (90) [45] _ 216 (90) [45] 417 (82) [29] 12 (75) [8] 405 (83) [30]
Surgery 695 (94) [44] 508 (94) [46] 187 (95) [38] 938 (89) [55] 639 (91) [64] 299 (86) [38]
Orthopedics 262 (72) [38] 178 (75) [34] 84 (68) [48] 266 (86) [23] 171 (88) [28] 95 (82) [13]
ENT 197 (95) [78] 111 (97) [77] 86 (92) [79] 53 (85) [38] 27 (89) [48] 26 (81) [27]
Ophthalmology 149 (99) [83] 76 (99) [80] 73 (100) [86] 7 (86) [20] 3 (100) [33] 4 (75) [75]
Pulmonary Medicine 225 (98) [41] 171 (99) [42] 54 (96) [37] 25 (88) [35] 19 (90) [16] 6 (83) [33]
ICU 116 (78) [3] 61 (77) [2] 55 (78) [6] 418 (75) [14] 256 (69) [5] 162 (75) [4]
Casualty 224 (80) [13] 124 (86) [13] 100 (75) [14] _ _ _
Private _ _ _ 771 (74) [4] 461 (73) [32] 310 (75) [39]
Total 3004 (78) [35] 1655 (85) [36] 1349 (79) [35] 5381 (79) [29] 2963 (81) [32] 2418 (77) [26]
n (%) [%]: Absolute number of admitted patients (percentage of inpatients on antibiotic during hospital stay) [percentage of inpatients prescribed antibiotic at
discharge]NICU =Neonatal Intensive care unit; Ob-Gy =Obstetrics and Gynecology; ENT = Ear, Nose and Throat; ICU= Intensive Care Unit.
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Table 3 Median duration of hospital stay and antibiotic treatment together with information about DDDs prescribed; by departments in a Teaching and a
Non-teaching hospital in Ujjain district, India
Teaching hospital Non-teaching hospital
Department




























































7 (1–25) 5 (1–26) 624 6 684 0.9 Pediatric
(n = 531)
3 (1–43) 4 (1–44) 2554 5 3124 0.8
NICU (n = 11) 7 (1–12) 5 (1–10) 6.3 0.6 53 0.1 NICU (n = 199) 5 (1–42) 6 (1–37) 257 1 1672 0.2
Medicine
(n = 476)
4 (1–56) 4 (1–56) 3474 7 2513 1.4 Medicine
(n = 1187)
3 (1–34) 3 (1–35) 10074 9 6089 1.7
Ob-Gy
(n = 194)
6 (1–63) 4 (1–55) 1667 9 1179 1.4 Ob-Gy (n = 343) 4 (1–16) 4 (1–15) 2250 7 2139 1.1
Surgery
(n = 654)
8 (1–88) 7 (1–89) 6911 11 5799 1.2 Surgery
(n = 835)
3 (1–30) 3 (1–31) 8203 10 4577 1.8
Orthopedics
(n = 188)
10 (1–69) 10 (1–63) 2963 12 2308 1.3 Orthopedics
(n = 228)
5 (1–137) 5 (1–17) 1871 8 1857 1.0
ENT (n = 187) 8 (1–38) 8 (1–32) 1404 8 1653 0.8 ENT (n = 45) 3 (1–9) 4 (1–8) 339 8 194 1.7
Ophthalmology
(n = 148)
5 (1–21) 7 (1–13) 904 6 883 1.0 Ophthalmology
(n = 6)




7 (1–50) 8 (1–50) 4923 22 3131 1.6 Pulmonary
Medicine
(n = 22)
3 (1–17) 4 (1–11) 253 12 155 1.6
ICU (n = 91) 3 (1–34) 3 (1–18) 628 7 419 1.5 ICU (n = 298) 2 (1–33) 3 (1–20) 2294 8 1261 1.8
Casualty
(n = 181)
3 (1–140) 3 (1–48) 959 5 986 1.0 Casualty (n = 0) 0 0 0 0 0 0
Private (n = 0) - 0 0 0 0 0 Private (n = 567) 3 (1–42) 3 (1–16) 4332 8 2856 1.5
Total 6 (1–140) 6 (1–89) 24465 10 19608 1.2 Total 3 (1–137) 4 (1–62) 32542 8 23956 1.4




















Table 4 Distribution of prescribed anti-infectives; by groups, subgroups and ATC codes; in a Teaching and a Non-
teaching hospital in Ujjain district, India
Antibiotics groups/subgroups with ATC codes Teaching hospital Non-teaching hospital
n (%) n (%)
Total prescribing occasions 30311 (100) 35534 (100)
ANTIBACTERIALS FOR SYSTEMIC USE; J01 25867 (85.3) 35427 (99.7)
Tetracyclines; J01A Tetracyclines; J01AA 2235 (7.4) 94 (0.2)
Amphenicols; J01B Amphenicols; J01BA 40 (0.1) 0 (0.0)
β- lactam antibiotics, penicillin; J01C 3100 (10.2) 3268 (9.8)
Penicillins with extended spectrum; J01CA 778 (2.6) 808 (2.3)
Beta-lactamase sensitive penicillins; J01CE 3 (0.0) 18 (0.0)
Beta-lactamase inhibitors; J01CG 5 (0.0) 2 (0.0)
Combination of penicillin including
beta lactamase antibiotics; J01CR
2314 (7.6) 2440 (7.4)
Other beta lactam; J01D 4333 (14.3) 11929 (33.3)
1st generation Cephalosporins; J01DB 645 (2.1) 135 (0.4)
2nd generation Cephalosporins; J01DC 2 (0.0) 516 (1.4)
3rd generation Cephalosporins; J01DD 3686 (12.2) 11174 (31.3)
Fourth-generation Cephalosporins; J01DE 0 (0.0) 51 (0.1)
Carbapenems J01DH 0 (0.0) 53 (0.1)
Sulfonamide with Trimethoprim; J01E Combination of Sulfonamide with
Trimethoprim; J01EE
928 (3.1) 6 (0.01)
Macrolides, lincosamides; J01F 842 (2.8) 150 (0.6)
Macrolides; J01FA 58 (0.2) 78 (0.3)
Lincosamides; J01FF 784 (2.6) 72 (0.3)
Aminoglycoside; J01G 4068 (13.4) 3484 (10.2)
Streptomycin; J01GA 212 (0.7) 4 (0.0)
Other Aminogylcosides; J01GB 3856 (12.7) 3480 (10.2)
Quinolones; J01M Fluoroquinolones; J01MA 6887 (22.7) 4156 (11.7)
Combination of antibiotics; *J01R Combination of Antibiotics; *J01RA 1194 (3.9) 9084 (25.1)
Other antibiotics; J01X 2240 (7.4) 3256 (8.8)
Glycopeptide antibacterials; J01XA 6 (0.0) 16 (0.0)
Imidazole derivatives; J01XD 2216 (7.3) 3173 (8.6)
Nitrofurantoin; J01XE 18 (0.1) 5 (0.0)
Other antibacterials; J01XX 0 (0.0) 62 (0.2)
DRUGS FOR TREATMENT OF TUBERCULOSIS; J04 2257 (7.5) 7 (0.02)
Drugs for treatment of Tuberculosis; J04A
Antibiotics; J04AB 574 (1.9) 7 (0.02)
Hydrazides; J04AC 570 (1.9) 0 (0.0)
Other drugs for treatment of
tuberculosis; J04AK
1113 (3.7) 0 (0.0)
AGENTS AGAINST AMOEBIASIS &
OTHER PROTOZOAL DISEASES P01;
2187 (7.2) 100 (0.3)
Agents against amoebiasis
& protozoal diseases; P01A
Nitroimidazole derivatives; P01AB 2187 (7.2) 95 (0.3)
Other agents against amoebiasis
& other protozoal diseases; P01AX
0 (0.0) 5 (0.01)
n (%): Absolute number of prescribing occasions (percentage of total prescribing occasions).
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that visits of MRs to prescribers are restricted in the TH
as per policy decision, but not in the NTH. Also, regular
academic deliberations and Continuing Medical Education
(CME) programs held in the TH are likely to influence the
prescribing there.
A total of 18 and 30 FDCs were prescribed in the TH
and in the NTH respectively, out of which only 2 (co-
trimoxazole, and ampicillin with clavulanic acid) are
included in WHOEDL [29]. Many new FDCs of antibio-
tics have no underlying scientific justification. In the
NTH 25% of all prescribing occasions were of new
FDCs of antibiotics (*J01RA), of which almost all were a
combination of 3rd generation cephalosporins with β-
lactamase inhibitors. Prescribing the combinations of
cephalosporin with β-lactamse inhibitor are justified in
cases of ESBL producing strains of E. coli and Klebsiella
and thus to keep carbapenems as reserve medicines.
However, as most of the prescribing in our setting was
empirical we cannot evaluate in what percentage of pre-
scriptions, these combinations were justified.
In fixed dose combination of ampicillin and cloxacillin;
cloxacillin is the anti-staphylococcal penicillin and is not
effective against gram negative bacilli, whereas ampicillin
is effective against certain gram negative bacilli but not
effective against staphylococci. Staphylococcal and gram
negative bacillary infections rarely coexist; except in
cases of diabetic foot and some polymicrobial skin infec-
tions. In all other infections such a combination would
most likely not contribute to resolve the infection. Fur-
thermore in the available combination the dose of each
drug is only half of the recommended [40]. Also both
the medicines are ineffective in the case of methicillin
resistant staphylococcal infections. The use of such com-
binations adds to the cost of therapy, results in adverse
effects and encourages resistance. In light of the above
facts the FDCs of ampicillin with cloxacillin and amoxicil-
lin with cloxacillin was removed from the list of antibiotics
recommended by the local Medicine and Therapeutics
Committee in a Nepalese teaching hospital [41].
Despite of very few patients of diabetic foot (0.3% of
total patients in the TH and 0.5% in the NTH) and poly-
microbial skin infections (TH-0.5% and NTH-0.2%) ad-
mitted in the setting (unpublished data) the combination
of ampicillin with cloxacillin was prescribed in 6% of
prescribing occasions in the TH. The polymicrobial skin
infections were mainly treated by local antibacterial
medicines (Povidone-Iodine). The reason for prescribing
a combination of ampicillin with cloxacillin in the set-
ting is probably due to an empirical approach taken by
the physicians in cases of unclear etiology.
Antibiotic prescribing was more common in younger
patients in the NTH compared within the TH. More
young female patients (5–18 years) than males were pre-
scribed antibiotics in the TH, which may be because
young female patients usually visit hospitals with more
severe infections than young male patients in rural areas.
This might be due to a gender bias and poorer care of
girls particularly in rural areas, which has previously
been noted in a healthcare utilization study in western
India [29, 42].
The median duration of stay and the median duration
of antibiotic therapy were higher in the TH than in the
NTH. One of the reasons might be the free medical care
and medicines provided to the patients in the TH. How-
ever, a longer stay in hospital not only increases the risk
of healthcare associated infections [43] and the use of
antibiotics but also may lead to an increase the required
time period of antibiotic treatment.
The results show a higher percentage of patients pre-
scribed antibiotics in the rurally located hospital (TH),
which is similar to a disease specific study done in Uttar
Pradesh, India [30] but is different from a public sector
study in Madhya Pradesh [44] which showed higher
antibiotic prescribing rates in urban hospitals.
Methodological considerations
The strength of this study is the detailed record of pre-
scribing data of individual patients throughout their hos-
pital stay. The two hospitals had many departments, so
the study provides a broad view of antibiotic prescribing.
The study has a novel concept, to compare the antibiotic
prescribing in two private sector hospitals (TH and
NTH) in same area. The data presented is the result of a
carefully conducted study as presented in method
section.
As per WHOCC we have coded oral metronidazole as
agents against amoebiasis and other protozoal diseases
(P01), and not as anti-infectives (J01). In NEDL [27],
however, oral metronidazole is also listed under antibac-
terials for anaerobic infections, and was therefore con-
sidered as an anti-infective.
The DDD is the best available technical unit for compar-
ing the use of medicines within and between different
countries, including different drug substances [31, 45, 46].
However, as it is based on adult dosages, adult and pediatric
patients cannot be compared. Therefore some other unit,
such as prescribing occasion, as used in this paper, is also
needed for comparative purposes. In addition, doses some-
times vary according to the diagnosis, but only one DDD
per generic substance is given by WHOCC.
The manual data collection was possible because of
the high levels of commitment of the nursing staff of
both hospitals. There will however, be inevitably be some
missing data.
Conclusions
This study shows extensive antibiotic prescribing in both
hospitals, and highlights major problems of empirical
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antibiotic prescribing. The results also point towards a
situation of common prescribing of newer groups of
antibiotics, and the use of trade name prescribing in
both the hospitals. Lower adherence to NEDL and ex-
tensive use of broad spectrum and newer groups of anti-
biotics in the NTH was found. The result shows an
urgent need to follow antibiotic prescribing patterns for
a longer period and to formulate and implement con-
textually appropriate antibiotic prescribing guidelines,
based on local antibiotic prescribing and resistance pat-
terns. There is also a need of continuous local antibiotic
stewardship program. The need of periodic updating of
NEDL, as done for WHO EDL, was also felt.
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